Metabasis Therapeutics Inc - La Jolla, California 92037

Metabasis Therapeutics Inc is categorized under in La Jolla, CA .

Business Name: Metabasis Therapeutics Inc
Contact Person: John L Higgins
Address: 11085 North Torrey Pines Road # 300, La Jolla, California 92037
Phone Number: (858) 550-7500
Website Address: ligand.com
Annual Revenue (USD): Unknown
Founding Year: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category:
SIC Code: 2834
NAICS Code: 325412
Share This Business:
Related Businesses: Auspex Pharmaceuticals Inc - La Jolla, CA 92037
Merck & CO Inc - La Jolla, CA 92037
Sova Pharmaceuticals Inc - La Jolla, CA 92037
Neuro Map LLC - La Jolla, CA 92037
Cebix Inc - La Jolla, CA 92037
Transdel Pharmaceuticals Inc - La Jolla, CA 92037
Anaborex Inc - La Jolla, CA 92037
Chemokine Pharmaceutical Inc - La Jolla, CA 92037
Sanrx Pharmaceuticals, Inc - La Jolla, CA 92037
Ligand Pharmaceuticals Inc - La Jolla, CA 92037
Kuck Julie MD - La Jolla, CA 92037
Orexigen Therapeutics Inc - La Jolla, CA 92037
Kanisa Pharmaceuticals Inc - La Jolla, CA 92037
Kyowa Hakko Kirin California - La Jolla, CA 92037
Columbia U S A - La Jolla, CA 92037
Innovus Pharmaceuticals Inc - La Jolla, CA 92037
Singularis Inc - La Jolla, CA 92037

The company Metabasis Therapeutics Inc provides BOTH services in the form of from its single location in California. 1 to 4 employees work for Metabasis Therapeutics Inc, and the business now earns Unknown per annum.

Metabasis Therapeutics Inc was launched in 2010 and is classified under SIC code and category 2834 , and NAICS number and grouping 325412 . To contact Metabasis Therapeutics Inc, please call John L Higgins with the phone number (858) 550-7500 or visit its single location at 11085 North Torrey Pines Road # 300 in La Jolla, California 92037.

The location of the single location can also be found using the coordinates 32.907399,-117.243618. Read more details about this business on the webpage ligand.com or follow the company’s social media accounts, on Twitter and on Facebook.